IMC Chicago’s Biohaven BHVN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$836K Buy
98,800
+15,100
+18% +$165K ﹤0.01% 3461
2025
Q4
$945K Buy
83,700
+38,800
+86% +$481K ﹤0.01% 3017
2025
Q3
$674K Buy
44,900
+23,500
+110% +$342K ﹤0.01% 2977
2025
Q2
$302K Buy
+21,400
New +$381K ﹤0.01% 3104

Other funds holding BHVN

IMC Chicago's BHVN Position: Q1 2026 in Review

IMC Chicago reduced its Biohaven (BHVN) stake by 55% in Q1 2026, selling an estimated $298K and leaving 22,080 shares worth $187K. The position accounts for ﹤0.01% of the portfolio, ranked #5058.

IMC Chicago first reported a position in BHVN in Q4 2025 and has held it in 2 quarters since. The position peaked at $557K in Q4 2025. 275 funds tracked by Wall St. Rank hold BHVN as of Q1 2026.

  • IMC Chicago held 22,080 shares of Biohaven worth $187K as of Q1 2026.
  • IMC Chicago sold 27,255 Biohaven shares in Q1 2026, an estimated $298K.
  • Biohaven made up ﹤0.01% of IMC Chicago's portfolio in Q1 2026, its #5058 holding.
  • IMC Chicago first reported a position in Biohaven in Q4 2025 and has held it in 2 quarters since.
  • IMC Chicago's Biohaven position peaked at $557K in Q4 2025.
  • 275 funds tracked by Wall St. Rank held Biohaven as of Q1 2026.

Based on IMC Chicago's 13F filing for Q1 2026, filed 5 May 2026.